ABUS
Arbutus Biopharma Corporation Common Stock
stockNASDAQ
Market OpenNov 10, 2026 1:44:28 PM EST
3.81USD+2.419%(+0.09)1,110,399
Pre-marketNov 10, 2026 9:25:30 AM EST
3.71USD-0.269%(-0.01)
ABUS Financials
In Q3 FY 2026 (ended ), Arbutus Biopharma Corporation Common Stock (ABUS) reported revenue of $299K, net income of $59.12M, operating cash flow of $239.81M, and assets of $339.7M (filed ).
Loading financial statements…